Mount Sinai Researchers Develop A Multi-Target Approach To Treating Tumors
Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments. The result is an investigational compound AD80 that precisely targets multiple cancer genes. Tested in mouse models, the drug proved far more effective and less toxic than standard cancer drugs, which generally focus on a single target. "We've come up with one drug that hits multiple targets through 'rational polypharmacology,' and our approach represents a new concept we believe will have great success in suppressing tumors," said Ross L. Cagan, Ph.D., Professor and Associate Dean at Mount Sinai School of Medicine.
- Dr. Ross L. Cagan, Associate Dean Of The Graduate School Of Biological Sciences, Professor Developmental and Regenerative Biology, Oncological Sciences, and Ophthalmology, Mount Sinai School of Medicine
Learn more: http://www.healthcanal.com/cancers/29979-Mount-Sinai-Researchers-Develop-Multi-Target-Approach-Treating-Tumors.html
New Research Reveals Autism Risk Genes Are Shared Across Ancestries
Mar 30, 2026 View All Press Releases
New Study Links Altered Cellular States to Brain Structure
Jan 22, 2026 View All Press Releases
Mount Sinai Study Finds PTSD May Accelerate Brain Aging in 9/11 Responders
Dec 08, 2025 View All Press Releases